Cross Country Healthcare (CCRN) Jefferies Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Healthcare Conference summary
1 Feb, 2026Market trends and demand normalization
Demand for temp staffing declined through 2023 and early 2024 but has now stabilized, though not yet at pre-pandemic or normal levels.
Structural disconnect persists: open orders are below pre-pandemic levels, but clinician assignments remain high.
No significant rise in cancellations or fall in renewal rates; market may rebound in the second half of 2024.
Hospitals are reducing contingent labor despite high utilization, exploring virtual nursing and internal travel pools.
Internal travel pools have seen some success but face challenges in maintaining clinician pipelines without national reach.
Shifts in staffing models and technology
Industry is moving toward a blend of managed service programs (MSPs) and vendor-neutral agreements, with clients seeking both technology and service level agreements.
Launch of proprietary vendor management system (Intellify) in early 2023 enables participation in vendor-neutral opportunities.
Recent wins with sizable clients and a robust pipeline signal growth potential in spend under management.
Competitive advantage comes from brand reputation, recruiter relationships, breadth of opportunities, and technology platforms for both candidates and clients.
Financial dynamics and margin trends
Margins are similar between MSP and vendor-neutral models when managing own clients, but vendor-neutral offerings can have higher profit margins due to sub-vendor fees.
Vendor-neutral programs often cover larger portions of client systems, increasing spend under management.
Bill rates have stabilized at a normalized level, with little downward pressure and some signs of improvement in open order rates.
Pay rates for travelers have declined faster than bill rates, improving margins, but housing and incidentals subsidies remain elevated.
Bill rates are up 20%-25% compared to pre-pandemic, and there is no current difficulty in filling assignments.
Latest events from Cross Country Healthcare
- 2025 saw revenue and profit declines, but 2026 is set for sequential growth and margin gains.CCRN
Q4 20255 Mar 2026 - Q2 revenue fell 37% to $339.8M, with net loss of $16.1M but strong cash flow and tech gains.CCRN
Q2 20242 Feb 2026 - AI-driven staffing platforms and market expansion position the firm for strong, sustainable growth.CCRN
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 2024 revenue dropped 29% year-over-year, with margin pressure and mixed segment trends.CCRN
Q3 202416 Jan 2026 - Shareholders to vote on a $18.61/share cash merger, with board unanimous support and appraisal rights.CCRN
Proxy Filing1 Dec 2025 - Acquisition by Aya Healthcare announced, pending shareholder approval and regulatory review.CCRN
Proxy Filing1 Dec 2025 - Stockholders to receive $18.61 per share in cash in a board-approved merger, with a 67% premium.CCRN
Proxy Filing1 Dec 2025 - Aya to acquire Cross Country Healthcare for $18.61/share in a $615M all-cash merger.CCRN
Proxy Filing1 Dec 2025 - Cross Country to be acquired by Aya Healthcare, pending shareholder approval and regulatory review.CCRN
Proxy Filing1 Dec 2025